Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, HTG Molecular Diagnostics Partner to Develop CDx Tests for Pharma

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics and Qiagen Manchester Ltd., a wholly owned subsidiary of Qiagen, said today that they have inked a master assay development, commercialization, and manufacturing agreement.

The agreement creates a framework for the companies to combine their technological and commercial strengths to offer pharmaceutical companies a complete next-generation sequencing-based solution for the development and commercialization of companion diagnostic tests, with a focus on oncology.

As part of the agreement, Qiagen North American Holdings, another Qiagen subsidiary, has made a minority investment of an undisclosed amount in HTG.

"Our objective is to develop a complete NGS solution from biomarker discovery to commercialized companion diagnostics and we believe this agreement accelerates both companies' efforts. We are excited to offer this solution to customers," HTG President and CEO TJ Johnson said in a statement.

"HTG's extraction-free technology can add attractive capabilities to Qiagen's NGS-based sample-to-insight solutions for applications in pathology where sample often is limited," Kai te Kaat, vice president and head of franchise oncology for Qiagen's molecular diagnostics business area, added in a statement.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.